Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transplant Proc ; 52(1): 162-168, 2020.
Article in English | MEDLINE | ID: mdl-31901320

ABSTRACT

BACKGROUND: This study aimed to evaluate predictive factors for graft loss in patients who received kidney transplantation (KT) from living kidney donors (LKDs) at a single institute in Japan. METHODS: Our study focused on patients with end-stage renal disease who underwent KT from LKDs and were followed up for at least 1 year after surgery. The primary end point was graft survival (GS). GS after KT was analyzed using the Kaplan-Meier method. GS according to subgroup classification was analyzed using the log-rank test. A multivariate analysis was performed using a Cox proportional hazard model. RESULTS: The median follow-up period was 105.5 months after KT. The 5- and 10-year GS rates were 97.8% and 96.0% in KT recipients (KTRs) without posttransplant diabetes mellitus (PTDM) and 89.9% and 63.2% in those with PTDM, respectively. The rate of graft loss was significantly higher in KTRs with PTDM than in those without PTDM (P < .001). Of the KTRs whose diabetes mellitus (DM) was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss. In the multivariate analysis, the serum creatinine level at 1 month after KT, PTDM, and human leukocyte antigen mismatches were significantly associated with graft loss after KT. CONCLUSIONS: In this study, the rate of graft loss in KTRs with PTDM was significantly higher than that of KTRs without PTDM. However, among KTRs whose DM was cured after KT, those who underwent dialysis because of diabetic nephropathy had no graft loss.


Subject(s)
Diabetes Mellitus, Type 2/complications , Graft Survival , Kidney Failure, Chronic/complications , Kidney Transplantation/adverse effects , Postoperative Complications , Adult , Female , Humans , Japan , Kidney Failure, Chronic/surgery , Kidney Transplantation/mortality , Living Donors , Male , Middle Aged , Multivariate Analysis , Proportional Hazards Models , Risk Factors , Survival Rate
2.
Neuroreport ; 27(9): 671-6, 2016 06 15.
Article in English | MEDLINE | ID: mdl-27145228

ABSTRACT

Patients with Alzheimer's disease (AD) experience a wide array of cognitive deficits, which typically include the impairment of explicit memory. In previous studies, the authors reported that a flavonoid, quercetin, reduces the expression of ATF4 and delays memory deterioration in an early-stage AD mouse model. In the present study, the effects of long-term quercetin intake on memory recall were assessed using contextual fear conditioning in aged wild-type mice. In addition, the present study examined whether memory recall was affected by the intake of quercetin-rich onion (a new cultivar of hybrid onion 'Quergold') powder in early-stage AD patients. In-vivo analysis indicated that memory recall was enhanced in aged mice fed a quercetin-containing diet. Memory recall in early-stage AD patients, determined using the Revised Hasegawa Dementia Scale, was significantly improved by the intake of quercetin-rich onion (Quergold) powder for 4 weeks compared with the intake of control onion ('Mashiro' white onion) powder. These results indicate that quercetin might influence memory recall.


Subject(s)
Antioxidants/therapeutic use , Conditioning, Psychological/drug effects , Fear/drug effects , Memory Disorders/drug therapy , Quercetin/therapeutic use , Aged , Aged, 80 and over , Alzheimer Disease/complications , Alzheimer Disease/diagnostic imaging , Aniline Compounds , Animals , Benzothiazoles/pharmacokinetics , Female , Humans , Iofetamine/pharmacokinetics , Magnetic Resonance Imaging , Male , Memory Disorders/diagnostic imaging , Memory Disorders/etiology , Mental Recall/drug effects , Mental Status and Dementia Tests , Mice , Mice, Inbred C57BL , Neuropsychological Tests , Positron-Emission Tomography , Thiazoles
3.
Neurobiol Aging ; 36(9): 2509-18, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26070242

ABSTRACT

The production of amyloid ß (Aß) in the brain from Aß precursor protein (APP) through γ-secretase is important for the pathogenesis of Alzheimer's disease (AD). Our previous studies have demonstrated that autophagy impairment and endoplasmic reticulum stress increase presenilin 1 expression and enhance γ-secretase activity through the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and the translation of activating transcription factor 4 (ATF4). However, the inhibitory molecules for γ-secretase are largely unknown. Here, we demonstrate that the levels of ATF4 expression are increased in the brain of APP23 AD model mice; furthermore, these levels enhanced in the brain of APP23 mice crossed with obese and diabetic db/db (Lepr(db/db)) mice. A polyhydroxylated flavonoid, quercetin, suppressed presenilin 1 expression and Aß secretion in autophagy-impaired cells by the induction of growth arrest and DNA damaged-inducible gene (GADD) 34, which mediates eIF2α dephosphorylation, leading to decreased ATF4 expression. GADD34 induction was observed in the brain of wild-type mice, and APP23 mice fed quercetin in their diet. After the long-term feeding of quercetin, deterioration in memory assessed by freezing behavior was delayed in APP23 mice. These results indicate that quercetin may reduce eIF2α phosphorylation and ATF4 expression through GADD34 induction in the brain, leading to the improvement of memory in aged mice and the delay of deterioration in memory at the early stage of AD in AD model mice.


Subject(s)
Alzheimer Disease/drug therapy , Antioxidants/pharmacology , DNA-Binding Proteins/metabolism , Gene Expression Regulation/drug effects , Protein Phosphatase 1/metabolism , Quercetin/pharmacology , Transcription Factors/metabolism , Activating Transcription Factor 4/metabolism , Alzheimer Disease/complications , Alzheimer Disease/genetics , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/pharmacology , Amyloid beta-Protein Precursor/genetics , Animals , Antioxidants/therapeutic use , Autophagy-Related Protein 5 , Brain/drug effects , Brain/metabolism , Conditioning, Classical/drug effects , Disease Models, Animal , Gene Expression Regulation/genetics , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microtubule-Associated Proteins/metabolism , Peptide Fragments/pharmacology , Phosphorylation/drug effects , Presenilin-1/metabolism , Quercetin/therapeutic use , Receptors, Leptin/genetics , Receptors, Leptin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...